Free Trial
CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

Acasti Pharma logo
C$0.58 +0.01 (+1.75%)
(As of 03/27/2023)

About Acasti Pharma Stock (CVE:ACST)

Key Stats

Today's Range
C$0.56
C$0.58
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.47
C$1.66
Volume
2,450 shs
Average Volume
6,576 shs
Market Capitalization
C$25.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

ACST Stock News Headlines

Popular Stocks at Risk Under Trump—Are You Holding These?
The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely to lose big time now that Donald Trump has been re-elected
ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025
Acasti Pharma Inc. (ACST)
Acasti Pharma Inc. Class A
See More Headlines

ACST Stock Analysis - Frequently Asked Questions

Acasti Pharma's stock was trading at C$0.58 on January 1st, 2024. Since then, ACST stock has increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here
.

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acasti Pharma investors own include Genius Brands International (GNUS), Tesla (TSLA), Workhorse Group (WKHS), Nikola (NKLA), SCYNEXIS (SCYX) and Block (SQ).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Net Income
C$-17,250,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$115,000.00
Cash Flow
C$0.93 per share
Book Value
C$2.17 per share

Miscellaneous

Free Float
N/A
Market Cap
C$25.87 million
Optionable
Not Optionable
Beta
1.22
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (CVE:ACST) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners